# Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients

> **NCT04366960** · PHASE3 · COMPLETED · sponsor: **Niguarda Hospital** · enrollment: 189 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT04366960
- **Lead sponsor:** Niguarda Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-14
- **Primary completion:** 2021-05-25
- **Final completion:** 2021-05-25
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2021-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04366960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04366960, "Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04366960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*